Literature DB >> 1161982

Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine.

T Furukawa, I Ushizima, N Ono.   

Abstract

Different groups of mice were injected s.c. daily with lithium chloride in three doses(0.52, 1.58 and 4.72meg/kg) or with saline for a period of 3 weeks. Lithium administered acutely or chronically did not affect spontaneous locomotor activities. However, methamphetamine-induced hyper-locomotor activities were inhibited in the lithium groups as compared with those in the saline group, while the hyper-locomotor activities induced by tetrabenazine in the nialamide-pretreated animals were reduced to some extent but not significantly by lithium. Tetrabenazine brought about an initial transient increase followed by a decrease of spontaneous locomotor activities in the lithium groups, whereas it induced only a decrease of the activities in the saline group. In addition, jumping and vertical jumping behaviors, which were not observed in the saline group, occurred 30-60 min after tetrabenazine in the lithium groups. These effects of lithium tended to increase with an increase of the doses administered and with a prolongation of its daily administration. The results demonstrate that lithium modifies behavioral responses to methamphetamine and tetrabenazine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1161982     DOI: 10.1007/bf00421263

Source DB:  PubMed          Journal:  Psychopharmacologia


  12 in total

1.  Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study.

Authors:  T Okuma; K Inanaga; S Otsuki; K Sarai; R Takahashi; H Hazama; A Mori; M Watanabe
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

2.  Haloperidol and lithium blocking of the mood response to intravenous methylphenidate.

Authors:  D Wald; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

3.  Serotonergic function in mouse head twitches induced by lithium and reserpine.

Authors:  K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

4.  Behavioral and pharmacological assessment of a potential new mouse model for mania.

Authors:  Melissa-Ann L Scotti; Grace Lee; Sharon A Stevenson; Alexandra M Ostromecki; Tyler J Wied; Daniel J Kula; Griffin M Gessay; Stephen C Gammie
Journal:  Physiol Behav       Date:  2011-03-22

Review 5.  Treatment strategies for dystonia.

Authors:  Leslie J Cloud; H A Jinnah
Journal:  Expert Opin Pharmacother       Date:  2010-01       Impact factor: 3.889

6.  Temporal and regional differences in brain concentrations of lithium in rats.

Authors:  B P Mukherjee; P T Bailey; S N Pradhan
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

7.  Jumping behavior induced by thyrotropin releasing hormone in combination with apomorphine in mice.

Authors:  I Ushijima; K Yamada; Y Noda; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats.

Authors:  R G Fessler; R D Sturgeon; S F London; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Lithium in combination with haloperidol or thyrotropin-releasing hormone induces jumping in mice.

Authors:  I Ushijima; K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.

Authors:  D P van Kammen; J P Docherty; S R Marder; J E Rosenblatt; W E Bunney
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.